CH EPL (R5)
0.1.0 - ci-build
CH EPL (R5)
0.1.0 - ci-build
CH EPL (R5), published by Federal Office of Public Health FOPH. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/bag-epl/bag-epl-fhir/ and changes regularly. See the Directory of published versions
| Active as of 2024-09-16 |
Mappings for the ch-idmp-administrableproductdefinition resource profile.
| CHIDMPAdministrableProductDefinition | ||
| AdministrableProductDefinition | administrative.medication | |
| identifier | FiveWs.class | |
| CHIDMPAdministrableProductDefinition | ||
| AdministrableProductDefinition | Pharmaceutical Product | |
| identifier | PhPID | |
| status | n/a | |
| formOf | (link to Medicinal Product) | |
| administrableDoseForm | Pharmaceutical Product.Administrable Dose Form | |
| unitOfPresentation | Pharmaceutical Product.Unit of Presentation | |
| producedFrom | n/a (this is the link from Pharmaceutical Product to the Manufactured Item(s)) | |
| ingredient | Pharmaceutical Product.Ingredient (see also FHIR Ingredient resource) | |
| device | Pharmaceutical Product.Device | |
| description | n/a | |
| property | Pharmaceutical Product Characteristics | |
| type | Pharmaceutical Product Characteristics.Code System (not a one to one map, the resource is more capable) | |
| value[x] | Pharmaceutical Product Characteristics.Value (not a one to one map, the resource is more capable) | |
| status | Pharmaceutical Product Characteristics.Status | |
| routeOfAdministration | Pharmaceutical Product.Route of Administration | |
| code | Route of Administration.Route of Administration | |
| firstDose | Dosing and Route of Administration.First dose in humans (Investigational Medicinal Product) | |
| maxSingleDose | Dosing and Route of Administration.Maximum single dose (Investigational Medicinal Product) | |
| maxDosePerDay | Dosing and Route of Administration.Maximum dose per day (Investigational Medicinal Product) | |
| maxDosePerTreatmentPeriod | Dosing and Route of Administration.Maximum dose per treatment period (Investigational Medicinal Product) | |
| maxTreatmentPeriod | Dosing and Route of Administration.Maximum treatment period (Investigational Medicinal Product) | |
| targetSpecies | n/a | |
| code | n/a | |
| withdrawalPeriod | n/a | |
| tissue | n/a | |
| value | n/a | |
| supportingInformation | n/a | |
| CHIDMPAdministrableProductDefinition | ||
| AdministrableProductDefinition | Entity, Role, or Act | |
| text | Act.text? | |
| contained | N/A | |
| extension | N/A | |
| modifierExtension | N/A | |
| identifier | ||
| id | n/a | |
| extension | n/a | |
| use | Role.code or implied by context | |
| type | Role.code or implied by context | |
| system | II.root or Role.id.root | |
| value | II.extension or II.root if system indicates OID or GUID (Or Role.id.extension or root) | |
| period | Role.effectiveTime or implied by context | |
| assigner | II.assigningAuthorityName but note that this is an improper use by the definition of the field. Also Role.scoper | |
| property | ||
| id | n/a | |
| extension | n/a | |
| modifierExtension | N/A | |
| routeOfAdministration | ||
| id | n/a | |
| extension | n/a | |
| modifierExtension | N/A | |
| targetSpecies | ||
| id | n/a | |
| extension | n/a | |
| modifierExtension | N/A | |
| withdrawalPeriod | ||
| id | n/a | |
| extension | n/a | |
| modifierExtension | N/A | |